EX-23.1 3 ex_156618.htm EXHIBIT 23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_156618.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We have issued our report dated August 29, 2019, with respect to the consolidated financial statements included in the Annual Report of Integrated Biopharma, Inc. on Form 10-K for the years ended June 30, 2019 and June 30, 2018. We hereby consent to the incorporation by reference of said report in the Registration Statements of Integrated BioPharma, Inc. on Forms S-8 (Nos. 333-229069, 333-37509, 333-87456 and 333-87458) and the Registration Statements on Forms S-3 (333-144155 and 333-149855).

 

 

/s/ Friedman LLP

East Hanover, New Jersey

August 29, 2019